Skip to main content

tenecteplase (Metalyse®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal TA990: Tenecteplase for treating acute ischaemic stroke

Medicine details

Medicine name tenecteplase (Metalyse®)
Formulation Powder and solvent for solution for injection
Reference number 5341
Indication

Thrombolytic treatment of acute ischaemic stroke

Company Boehringer Ingelheim Ltd
BNF chapter Cardiovascular system
Assessment type N/A
Status Excluded due to NICE appraisal
Date of issue 19/06/2024
NICE guidance

TA990: Tenecteplase for treating acute ischaemic stroke

Follow AWTTC: